Vernalis plc today announces its decision to cease further investment in V3381. An interim review of data from the small pilot study in chronic cough being undertaken in collaboration with Professor ...
RELX PLC (the “Company”) announces in compliance with the UK and EU Market Abuse Regulations that it will implement an irrevocable, non-discretionary programme to repurchase its ordinary shares ...
LONDON, UK / ACCESSWIRE / November 1, 2023 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company targeting diseases with a high unmet ...
LONDON, UK / ACCESSWIRE / June 29, 2023 / Poolbeg Pharma (AIM:POLB, OTCQB:POLBF, 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company focusing on infectious and other prevalent ...
Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Hosted on MSN
Informa PLC Updates Share Buyback Programme for 2025
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update from Informa ( (GB:INF)) is now ...
The Group announces that, as outlined in the announcement of its full year results for the year ended 31 December 2025 on 5 March 2026, it intends to commence on 6 March 2026, a share repurchase ...
On 10 June 2025 FirstGroup plc (the ‘Group’) announced an on-market share buyback programme to purchase up to £50m of ordinary shares (the ’Programme’), which commenced on 10 June 2025. The Group ...
Moonpig Group plc (the "Company") announces that further to the announcement on 3 April 2025, it is today commencing a H2 FY26 share buyback programme (the "Share Buyback Programme") to repurchase up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results